Matoba R
Department of Legal Medicine, Osaka University Graduate School, Suita, 565-0871, Japan.
Nihon Hoigaku Zasshi. 2001 Nov;55(3):321-30.
Various cardiac lesions such as hypertrophy, disarray and fibrosis similar to HCM, were often found in the heart of methamphetamine (MA) abusers. Myolysis, eosinophilic changes, contraction band necrosis and small round cell infiltration were also observed. Male ddy mouse were administered MA 1 mg/kg subcutaneously every day for 4 weeks. Their hearts revealed many cardiac changes such as hypertrophy, myolysis, contraction band necrosis, disarrangement of myofibers, saw-like cytoplasm, side-to-side connection of cardiac cells and vascuolative degeneration microscopically, and crysterosis of mitochondria, enlargement of sarcoplasmic reticulum and hypercontraction electronmicroscopically. These changes are thought to be similar to that of MA abusers, so it is certified that MA has toxic effect on the heart. Moreover, these changes could not be found when beta-blocker or calcium antagonist was premedicated. To elucidate the mechanisms of MA cardiac toxicity, we have designed some experiments. When MA (15 mg or 20 mg/kg) was administered on rats, cardiac lipid peroxidates, as a marker of free radical, increased rapidly. When rats were feeded for 7 weeks with Vitamin E deficient diet, 10 mg/kg MA administration was enough to increase lipid peroxidates. Simultaneous ECG observation revealed various arrhythmia such as VPB, A-V block and intraventricular conduction delay. In the investigation of contractile protein, although we could not find differences in the isozyme pattern of myosin heavy chain between MA groups (1 mg/kg for 8 and 12 weeks) and control group, Mg2+ ATPase activity of myocardial actomyosin at 0.1 microM Ca2+ increased significantly in 12 weeks MA group. We also found MA induced cardiac toxicity in cultured myocytes. Primary cultured adult rat myocytes were exposed to MA (1 x 10(-5) M and 1 x 10(-3) M) for 1 to 24 h in the presence and absence of 1 x 10(-5) M propranolol. After 24-h MA treatment, cellular granulation, swelling and hypercontraction and release of CPK were observed both with and without propranolol treatment. These findings suggest that MA may exert direct toxic effects on the heart.
在甲基苯丙胺(MA)滥用者的心脏中,经常发现各种心脏病变,如与肥厚型心肌病(HCM)相似的心肌肥厚、肌纤维排列紊乱和纤维化。还观察到了肌溶解、嗜酸性变、收缩带坏死和小圆细胞浸润。雄性ddy小鼠每天皮下注射1mg/kg的MA,持续4周。它们的心脏在显微镜下显示出许多心脏变化,如心肌肥厚、肌溶解、收缩带坏死、肌纤维排列紊乱、锯齿状细胞质、心肌细胞的侧向连接和空泡样变性,在电子显微镜下可见线粒体结晶、肌浆网扩大和过度收缩。这些变化被认为与MA滥用者的变化相似,因此证实MA对心脏有毒性作用。此外,在预先给予β受体阻滞剂或钙拮抗剂时,未发现这些变化。为了阐明MA心脏毒性的机制,我们设计了一些实验。当给大鼠注射MA(15mg或20mg/kg)时,作为自由基标志物的心脏脂质过氧化物迅速增加。当大鼠用缺乏维生素E的饮食喂养7周后,给予10mg/kg的MA就足以增加脂质过氧化物。同时进行的心电图观察显示出各种心律失常,如室性早搏、房室传导阻滞和室内传导延迟。在收缩蛋白的研究中,虽然我们在MA组(1mg/kg,持续8周和12周)和对照组之间未发现肌球蛋白重链同工酶模式的差异,但在12周MA组中,0.1μM钙离子浓度下心肌肌动球蛋白的镁离子ATP酶活性显著增加。我们还发现MA在培养的心肌细胞中诱导心脏毒性。原代培养的成年大鼠心肌细胞在有和没有1×10⁻⁵M普萘洛尔的情况下,暴露于MA(1×10⁻⁵M和l×10⁻³M)1至24小时。在24小时的MA处理后,无论有无普萘洛尔处理,均观察到细胞颗粒化、肿胀、过度收缩和肌酸磷酸激酶(CPK)释放。这些发现表明MA可能对心脏产生直接毒性作用。